NOTCH2 and endothelial dysfunction: Very recently, we have found that deregulation of Notch2 signalling in osteoblasts plays a central role in MTX chemotherapy-induced bone damage [50], and Notch2 has been previously shown to play an important role in inflammation-mediated endothelial dysfunction [21,27].